Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-24 @ 1:20 PM
NCT ID:
NCT01580995
Eligibility Criteria:
Inclusion Criteria:
* Chronic hepatitis C infection with a detectable HCV RNA in the serum on two occasions, 6 months apart
* Focus HSV-2 IgG negative and Focus HSV-1 IgG positive, using manufacturer's cut-offs
Exclusion Criteria:
* Antiherpes or immunomodulatory therapy during the past 30 days,
* HIV or chronic hepatitis B infection,
* Decompensated liver disease (ascites, hepatic encephalopathy, coagulopathy, jaundice/icterus),
* Creatinine clearance \<50 ml/min.,
* Female subject who is pregnant or nursing,
* Gastrointestinal disorder which might result in malabsorption of valacyclovir,
* History of erythema multiforme major, thrombotic thrombocytopenia purpura or hemolytic uremic syndrome,
* Allergy to valacyclovir or related drug.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01580995
Study Brief:
Protocol Section:
NCT01580995